Click Image To Read

Given the COVID-19 pandemic and the concerns some people living with diabetes may have about their risks and ability to access their medications, Sanofi, as one of the leading insulin manufacturers, wants to reassure people living with diabetes that they remain committed to offering innovative solutions to provide affordable access to medicines.

We've gathered trusted resources and valuable tips to help you navigate these trying times.
Check back often for the latest updates and additions.

A message from our CEO on DiabetesSisters COVID-19 response

Click Image To Read

Real People. Real Solutions.

The nurses and pharmacists at the Lilly Diabetes Solution Center are there for one reason: helping people. Call 833-808-1234 to speak with someone who may be able to help you meaningfully reduce the amount you pay for Lilly insulin based on your individual circumstances. They’re waiting for your call Monday through Friday, 9 a.m. to 8 p.m., ET.

Learn more:

Click Image To Read

New: VASCEPA® (icosapent ethyl) is Now FDA Approved to Reduce Heart Risk!

VASCEPA is now FDA approved, along with certain medicines (statins), to reduce the risk of heart attack, stroke and certain types of heart issues requiring hospitalization in adults with heart (cardiovascular) disease, or diabetes and 2 or more additional risk factors for heart disease.

Click Image To Read

Insulet Corporation Launches a First of its Kind Advocacy Website

Click Image To Read